Haematologica (Jan 2024)
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
- Linlin Xu,
- Mazyar Shadman,
- Ian W. Flinn,
- Moshe Y. Levy,
- Ryan Porter,
- John M. Burke,
- Syed F. Zafar,
- Jennifer L. Cultrera,
- Jamal Misleh,
- Edwin C. Kingsley,
- Habte A. Yimer,
- Benjamin Freeman,
- Arvind Chaudhry,
- Praveen K. Tumula,
- Mitul D. Gandhi,
- Rocco Crescenzo,
- Kunthel By,
- Aileen Cohen,
- Dih-Yih Chen,
- Adam Idoine,
- Sudhir Manda,
- Jeff P. Sharman,
- Vanitha Ramakrishnan
Affiliations
- Linlin Xu
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Mazyar Shadman
- Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
- Ian W. Flinn
- Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
- Moshe Y. Levy
- Texas Oncology Baylor Charles A. Sammons Cancer Center, Dallas, TX
- Ryan Porter
- SSM Health Dean Medical Group, Madison, WI
- John M. Burke
- Rocky Mountain Cancer Centers, Aurora, CO
- Syed F. Zafar
- Florida Cancer Specialists and Research Institute, Fort Myers, FL
- Jennifer L. Cultrera
- Florida Cancer Specialists and Research Institute, Leesburg, FL
- Jamal Misleh
- Medical Oncology Hematology Consultants PA, Newark, DE
- Edwin C. Kingsley
- Comprehensive Cancer Centers of Nevada, Las Vegas, NV
- Habte A. Yimer
- Texas Oncology, Tyler, TX
- Benjamin Freeman
- Summit Medical Group, Florham Park, NJ
- Arvind Chaudhry
- Summit Cancer Centers, Spokane, WA
- Praveen K. Tumula
- Texas Oncology, Amarillo, TX
- Mitul D. Gandhi
- Virginia Cancer Specialists, Gainesville, VA
- Rocco Crescenzo
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Kunthel By
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Aileen Cohen
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Dih-Yih Chen
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Adam Idoine
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- Sudhir Manda
- Arizona Oncology / US Oncology Research, Tucson, AZ, USA; and
- Jeff P. Sharman
- Willamette Valley Cancer Institute and Research Center, Eugene, OR
- Vanitha Ramakrishnan
- BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
- DOI
- https://doi.org/10.3324/haematol.2023.283861
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
